Ms. Gala was appointed president and chief executive officer, effective August 2025. She brings more than 30 years of experience across finance, strategy, corporate development and commercialization. Ms. Gala previously served as Jazz’s president and chief operating officer overseeing the company’s global business operations, which include commercial, medical, research and development, technical operations and quality, as well as corporate strategy. Ms. Gala previously served as Jazz’s chief financial officer from 2020 until being appointed as president and chief operating officer in 2023. Ms. Gala has played a critical role in driving Jazz’s ongoing transformation, including architecting a business development strategy that has diversified the Company’s portfolio, driven total revenue growth of nearly 90%, built broad capabilities, and established a pipeline that has positioned the Company for value creation and sustainable growth. Ms. Gala is a passionate proponent of improving diversity of thought and background, innovation and inclusion within the healthcare industry.